Clinical applications for cardiovascular magnetic resonance imaging at 3 Tesla

Current Cardiology Reviews

Volumn 5, Issue 3, 2009, Pages 237-242

  Hays, Allison G ^a   Schär, Michael ^a,b   Kelle, Sebastian ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPS HEALTHCARE   (United States)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

3 Tesla; Cardiac magnetic resonance

Indexed keywords

DOBUTAMINE; GADOLINIUM;

ANGIOCARDIOGRAPHY; BLOOD FLOW; CARBON NUCLEAR MAGNETIC RESONANCE; CARDIOVASCULAR DISEASE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TECHNOLOGY;

EID: 70449717526     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340309788970351     Document Type: Review

References (67)

1. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/ SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006; 48: 1475-1497
2. Gebker R, Jahnke C, Paetsch I, et al. Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology 2008; 247: 57-63.
3. Araoz PA, Glockner JF, McGee KP, et al. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 2005; 7: 559-564
4. Meyer C, Strach K, Thomas D, et al. High-resolution myocardial stress perfusion at 3 T in patients with suspected coronary artery disease. Eur Radiol 2008; 18: 226-233 (Pubitemid 351234042)
5. Strach K, Meyer C, Thomas D, et al. High-resolution myocardial perfusion imaging at 3 T: comparison to 1.5 T in healthy volunteers. Eur Radiol 2007; 17: 1829-1835 (Pubitemid 46909672)
6. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol 2006; 41: 661-667 (Pubitemid 44213742)
7. Cheng AS, Robson MD, Neubauer S, et al. Irreversible myocardial injury: assessment with cardiovascular delayed-enhancement MR imaging and comparison of 1.5 and 3.0 T--initial experience. Radiology 2007; 242: 735-742 (Pubitemid 46310085)
8. Kramer U, Deshpande V, Fenchel M, et al. Cardiac MR tagging: optimization of sequence parameters and comparison at 1.5 T and 3.0 T in a volunteer study. Rofo 2006; 178: 515-524
9. Valeti VU, Chun W, Potter DD, et al. Myocardial tagging and strain analysis at 3 Tesla: comparison with 1.5 Tesla imaging. J Magn Reson Imaging 2006; 23: 477-480
10. Stuber M, Botnar RM, Fischer SE, et al. Preliminary report on in vivo coronary MRA at 3 Tesla in humans. Magn Reson Med 2002; 48: 425-429 (Pubitemid 34951319)
11. Plein S, Bloomer TN, Ridgway JP, et al. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging 2001; 14: 230-236 (Pubitemid 32801056)
12. Fenchel M, Deshpande VS, Nael K, et al. Cardiac cine imaging at 3 Tesla: initial experience with a 32-element body-array coil. Invest Radiol 2006; 41: 601-608 (Pubitemid 44284167)
13. Wintersperger BJ, Bauner K, Reeder SB, et al. Cardiac steady-state free precession CINE magnetic resonance imaging at 3.0 tesla: impact of parallel imaging acceleration on volumetric accuracy and signal parameters. Invest Radiol 2006; 41: 141-147 (Pubitemid 44406211)
14. Noeske R, Seifert F, Rhein KH, et al. Human cardiac imaging at 3 T using phased array coils. Magn Reson Med 2000; 44: 978-982
15. Scheffler K, Lehnhardt S: Principles and applications of balanced SSFP techniques. Eur Radiol 2003; 13: 2409-2418 (Pubitemid 37407471)
16. Nael K, Fenchel M, Saleh R, et al. Cardiac MR imaging: new advances and role of 3T. Magn Reson Imaging Clin N Am 2007; 15: 291-300, v. (Pubitemid 47430008)
17. Schar M, Kozerke S, Fischer SE, et al. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 2004; 51: 799-806.
18. Fenchel M, Kramer U, Nael K, et al. Cardiac magnetic resonance imaging at 3.0 T. Top Magn Reson Imaging 2007: 18: 95-104. (Pubitemid 47051879)
19. Deshpande VS, Shea SM, Li D: Artifact reduction in true-FISP imaging of the coronary arteries by adjusting imaging frequency. Magn Reson Med 2003; 49: 803-809
20. Hinton DP, Wald LL, Pitts J, et al. Comparison of cardiac MRI on 1.5 and 3.0 Tesla clinical whole body systems. Invest Radiol 2003; 38: 436-442 (Pubitemid 36791338)
21. Michaely HJ, Nael K, Schoenberg SO, et al. Analysis of cardiac function - comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: preliminary experience. Invest Radiol 2006; 41: 133-140 (Pubitemid 44406210)
22. Gerretsen SC, Versluis B, Bekkers SC, et al. Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging. Eur J Radiol 2008; 65: 80-85
23. Hamdan A, Kelle S, Schnackenburg B, et al. Improved quantitative assessment of left ventricular volumes using TGrE approach after application of extracellular contrast agent at 3 Tesla. J Cardiovasc Magn Reson 2007; 9: 845-853 (Pubitemid 350232923)
24. Johnson T, Hahn D, Sandstede J. Quantitative analysis of left ventricular wall motion with MRI tagging. Radiologe 2004; 44: 158-163 (Pubitemid 38315909)
25. Osman NF, Kerwin WS, McVeigh ER, et al. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med 1999; 42: 1048-1060
26. Gutberlet M, Noeske R, Schwinge K, et al. Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: feasibility and implications for clinical applications. Invest Radiol 2006; 41: 154-167 (Pubitemid 44406213)
27. Korosoglou G, Youssef AA, Bilchick KC, et al. Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: comparison to conventional tagging. J Magn Reson Imaging 2008; 27: 1012-1018 (Pubitemid 351614611)
28. Youssef A, Ibrahim el SH, Korosoglou G, et al. Strain-encoding cardiovascular magnetic resonance for assessment of rightventricular regional function. J Cardiovasc Magn Reson 2008; 10: 33.
29. Sakuma H, Suzawa N, Ichikawa Y, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 2005; 185: 95-102.
30. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001; 103: 2230-2235 (Pubitemid 32433710)
31. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008; 29: 480-489 (Pubitemid 351264187)
32. Kim D, Axel L. Multislice, dual-imaging sequence for increasing the dynamic range of the contrast-enhanced blood signal and CNR of myocardial enhancement at 3T. J Magn Reson Imaging 2006; 23: 81-86
33. Cheng AS, Pegg TJ, Karamitsos TD, et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 2007; 49: 2440-2449
34. Plein S, Schwitter J, Suerder D, et al. k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology 2008; 249: 493-500.
35. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770
36. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007; 115: 1769-1776 (Pubitemid 46648614)
37. Kelle S, Hamdan A, Schnackenburg B, et al. Dobutamine Stress Cardiovascular Magnetic Resonance at 3 Tesla. J Cardiovasc Magn Reson 2008; 10: 44.
38. Isbell DC, Kramer CM. Magnetic resonance for the assessment of myocardial viability. Curr Opin Cardiol 2006; 21: 469-472 (Pubitemid 44215013)
39. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453 (Pubitemid 30832880)
40. Roes SD, Kelle S, Kaandorp TA, et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007; 100: 930-936 (Pubitemid 47368098)
41. Kelle S, Kokocinski T, Thouet T, et al. 1.5 vs. 3.0 Tesla - reduction of contrast agent dosage for scar-imaging possible? Euro Heart J 2006; 27: 422-423
42. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007; 115: 2006-2014 (Pubitemid 46625951)
43. Ibrahim el SH, Weiss RG, Stuber M, et al. Stimulated-echo acquisition mode (STEAM) MRI for black-blood delayed hyperenhanced myocardial imaging. J Magn Reson Imaging 2008; 27: 229-238
44. Gharib AM, Ho VB, Rosing DR, et al. Coronary artery anomalies and variants: technical feasibility of assessment with coronary MR angiography at 3 T. Radiology 2008; 247: 220-227
45. Bi X, Li D: Coronary arteries at 3.0 T: Contrast-enhanced magnetization-prepared three-dimensional breathhold MR angiography. J Magn Reson Imaging 2005; 21: 133-139
46. Sommer T, Hackenbroch M, Hofer U, et al. Coronary MR angiography at 3.0 T versus that at 1.5 T: initial results in patients suspected of having coronary artery disease. Radiology 2005; 234: 718-725 (Pubitemid 40250813)
47. Nezafat R, Stuber M, Ouwerkerk R, et al. B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med 2006; 55: 858-864
48. Huber ME, Kozerke S, Pruessmann KP, et al. Sensitivity-encoded coronary MRA at 3T. Magn Reson Med 2004; 52: 221-227
49. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 2008; 359: 2324-2336
50. Schuijf JD, Bax JJ, Shaw LJ, et al. Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J 2006; 151: 404-411 (Pubitemid 43144743)
51. Liu X, Bi X, Huang J, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T. Invest Radiol 2008; 43: 663-668
52. Desai MY, Lai S, Barmet C, et al. Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J 2005; 26: 2320-2324 (Pubitemid 41541398)
53. Kim WY, Stuber M, Bornert P, et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 2002; 106: 296-9.
54. Priest AN, Bansmann PM, Mullerleile K, et al. Coronary vessel-wall and lumen imaging using radial k-space acquisition with MRI at 3 Tesla. Eur Radiol 2007; 17: 339-346
55. Beer M: Cardiac spectroscopy: techniques, indications and clinical results. Eur Radiol 2004; 14: 1034-1047 (Pubitemid 38796431)
56. Bottomley PA: MR spectroscopy of the human heart: the status and the challenges. Radiology 1994;191: 593-612.
57. Bottomley PA, Weiss RG: Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-718
58. Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992; 86: 1810-1818
59. Smith CS, Bottomley PA, Schulman SP, et al. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006; 114: 1151-1158
60. Weiss RG, Bottomley PA, Hardy CJ, et al. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 1990; 323: 1593-1600.
61. Weiss RG, Gerstenblith G, Bottomley PA: ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci USA 2005; 102: 808-813 (Pubitemid 40282747)
62. Hammer S, van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008; 93: 497-503. (Pubitemid 351240822)
63. McGavock JM, Lingvay I, Zib I, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116: 1170-1175 (Pubitemid 47360218)
64. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008:93:2702-2708 (Pubitemid 352008539)
65. von Kienlin M: Methodological advances in cardiac 31P-MR spectroscopy. Magma (New York, NY) 2000; 11: 36-38
66. Schär M, Kozerke S, Boesiger P: Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 Tesla. Magn Reson Med 2004; 51: 1091-1095 (Pubitemid 38796991)
67. Tyler DJ, Hudsmith LE, Clarke K, et al. A comparison of cardiac (31)P MRS at 1.5 and 3 T. NMR Biomed 2008; 21: 793-798